Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 9,008 shares at $12.82 ($115K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($115k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.82 | 4,504 | $58K | 50.0% |
| 2 | $12.82 | 4,504 | $58K | 50.0% |
| Total | $12.82 avg | 9,008 | $115K | 100% |
| Filing → |
| STOK | SELL | 2026-08-18 | $153K | — | Filing → |
| STOK | SELL | 2026-08-05 | $208K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |